Cargando…
Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
The relationship between SMAD family member 4 (SMAD4) and the clinicopathological and prognostic significance of non-small cell lung cancer (NSCLC) patients is unclear. Our aim was to investigate the association between SMAD4 expression and clinicopathological parameters and NSCLC prognosis. METHODS...
Autores principales: | Li, Zhiqiang, Huang, Yunfei, Zhou, Rongsheng, Li, Zhicheng, Yan, Qitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662867/ https://www.ncbi.nlm.nih.gov/pubmed/37478236 http://dx.doi.org/10.1097/MD.0000000000034312 |
Ejemplares similares
-
Clinicopathological and prognostic significance of circRNAs in lung cancer: A systematic review and meta-analysis
por: Zheng, Yuxuan, et al.
Publicado: (2021) -
Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Chao, Dong, et al.
Publicado: (2021) -
The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis
por: Qiu, Weiwei, et al.
Publicado: (2022) -
Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis
por: Huang, Mengqin, et al.
Publicado: (2020) -
Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)